Clayton Petro
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Clayton Petro sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Clayton Petro: 5 sponsored US clinical trials, 1 recruiting.
Clayton Petro sponsors 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. 2 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Incisional Hernia, with 1 trials.
Upper-quartile sponsor footprint
Clayton Petro sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
Suture Repair vs Mesh Repair for Incisional Hernia
NCT05599750
No Opioids vs. Minimal Opioids Following Inguinal Hernia Repair
NCT05929937
The Impact of Sugammadex on Ileus After Abdominal Wall Reconstruction
NCT05985343
Anterior Gastropexy vs. No Anterior Gastropexy for Paraesophageal Hernia Repair
NCT04007952
Parastomal Hernia Repair Utilizing the Retromuscular Sugarbaker Versus Keyhole Mesh Techniques
NCT03972553
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 2 |
Therapeutic Areas
Where Clayton Petro enrollment is open (later-stage tilt)
1 recruiting of 5 indexed (20% open); 3 completed (60%).
Phase mix: 2 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Incisional Hernia (1 trial), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Clayton Petro: open-pipeline peers nationwide
Peers matched on 5 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
Clayton Petro sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
- Amazentis · 20% recruiting · 5 trials
Related
What to do with this Clayton Petro page
5 registered trials is a research-attention snapshot, not an endorsement of Clayton Petro or any single study.
- 1 of Clayton Petro's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Incisional Hernia is the condition Clayton Petro studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Incisional Hernia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Clayton Petro pipeline card: 5 registered trials from official public datasets.Report a data error.